News About: Pharm. Affairs
Poorly-performed osteoporosis market
Bisphosphonate(BP) drugs, osteoporosis treatments that are known to have particular administration, have recorded poor performances.
On the other hand, SERM-type drugs have become the only drugs which showed potentia...
“Are Gaviscon and Strepsils Oxy products?”
Although Oxy Reckitt Benckiser(current RB Korea) held the press conference for apology in 5 years after the humidifier germicide incident, the boycott does not seem to be calmed down against Oxy’s products.
Started ...
Which will take 2nd po2sition in anticoagulant market?
It’s getting more interesting and interesting. Competition is getting fiercer over the 2nd position for anticoagulants after warfarin.
According to the IMS’s data, the total prescriptions of new oral anticoagulants(N...
‘Stivarga Tab’ settled by RSA, becoming the 10th
The risk sharing agreement(RSA) for Stivarga Tab, a Bayer’s regorafenib gastrointestinal tumor treatment was settled. Thus, it became the 10th RSA-applied drug, starting with Evoltra Inj on December 2013.
The Nationa...
No. 1 birth control pill, Mercilon, hugged by Alvogen Korea
‘Mercilon Tab,’ a birth control pill that was sold the most in Korea, is now taken over by Alvogen Korea.
According to a confirmation on the 3rd, a company approved for Mercilon Tab was exchanged from Bayer Korea to...
‘Apology for criticism avoidance’ triggers boycott against Oxy
Although Oxy Reckitt Benckiser has announced the formal position for victims of the humidifier germicide incident, the boycott against its products will be more widely spread under the criticism that it was only an ‘a...
Contrave fluctuates obesity treatment market led by Belviq
Like the last year’s Belviq, new obesity treatments approved by the FDA are expected to fluctuate the domestic obesity treatment market.
According to the Ministry of Food and Drug Safety on the 2nd, Kwang Dong Pharma...
Biosimilar price set to 80% of the original, accepting contributions to domestic industry
Since the government is reviewing measures to set limits to the domestic industrial development related to raising biosimilar prices to 70% to 80% that the industry request, the industry paying attention to the result...
“It is lawful to return KRW 50,000 to Cialis patients”
When it comes to the marketing method to return cash to patients which received prescriptions of erectile dysfunction treatments, Lilly argued it is lawful.
It announced it get an authoritative interpretation from an...
“Can the regulation of reevaluation for modified drugs be improved?”
Although the pharmaceutical industry raised a voice towards preferential regulations for global expansion, such as standard relaxation of reevaluation on incrementally modified drugs, it seems it still needs more time...
